Literature DB >> 1714596

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

N W Kowall1, M F Beal, J Busciglio, L K Duffy, B A Yankner.   

Abstract

Deposition of the beta-amyloid protein in senile plaques is a pathologic hallmark of Alzheimer disease (AD). Focal deposition of beta amyloid in the adult rat cerebral cortex caused profound neurodegenerative changes, including neuronal loss and degenerating neurons and neurites. Chronic induction of the Alz-50 antigen appeared in neurons around focal cortical deposits of beta amyloid. Immunoblot analysis showed that beta amyloid induced Alz-50-immunoreactive proteins in rat cerebral cortex that were very similar to the proteins induced in human cerebral cortex from patients with AD. The neuropeptide substance P prevented beta-amyloid-induced neuronal loss and expression of Alz-50 proteins when coadministered into the cerebral cortex. Systemic administration of substance P also provided protection against the effects of intracerebral beta amyloid. Thus, beta amyloid is a potent neurotoxin in the adult brain in vivo, and its effects can be blocked by substance P.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714596      PMCID: PMC52271          DOI: 10.1073/pnas.88.16.7247

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

Authors:  B A Yankner; L R Dawes; S Fisher; L Villa-Komaroff; M L Oster-Granite; R L Neve
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

2.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

3.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

Authors:  B Rumble; R Retallack; C Hilbich; G Simms; G Multhaup; R Martins; A Hockey; P Montgomery; K Beyreuther; C L Masters
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

4.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

5.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Alzheimer-related neuronal protein A68: specificity and distribution.

Authors:  B Wolozin; P Davies
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

7.  Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.

Authors:  C L Joachim; H Mori; D J Selkoe
Journal:  Nature       Date:  1989-09-21       Impact factor: 49.962

8.  Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.

Authors:  M F Beal; M F Mazurek
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

9.  Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease.

Authors:  B Wolozin; A Scicutella; P Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Alz-50 antibody recognizes Alzheimer-related neuronal changes.

Authors:  B T Hyman; G W Van Hoesen; B L Wolozin; P Davies; L J Kromer; A R Damasio
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

View more
  87 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

3.  Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine.

Authors:  K Shigematsu; P L McGeer
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

Review 4.  Amyloidosis in aging and Alzheimer's disease.

Authors:  D L Price; L C Walker; L J Martin; S S Sisodia
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

5.  Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.

Authors:  K Toide; T Fujiwara; Y Iwamoto; M Shinoda; K Okamiya; T Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

6.  Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

Authors:  Alejandra N Martinez; Mario T Philipp
Journal:  J Neurol Neuromedicine       Date:  2016

7.  Protective effects and mechanism of total coptis alkaloids on a beta 25-35 induced learning and memory dysfunction in rats.

Authors:  Zheng-qin Yang; Su-fen Yang; Jun-qing Yang; Qi-xin Zhou; Shao-lin Li
Journal:  Chin J Integr Med       Date:  2007-03       Impact factor: 1.978

8.  A selective tachykinin receptor agonist promotes differentiation but not survival of rat chromaffin cells in vitro.

Authors:  R Barker; S Dunnett; J Fawcett
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 9.  Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

Authors:  A J Rozemuller; R A Roos; G T Bots; W Kamphorst; P Eikelenboom; W E Van Nostrand
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].

Authors:  O M El-Agnaf; G B Irvine; G Fitzpatrick; W K Glass; D J Guthrie
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.